Bjørn Atle Bjørnbeth
- CEO Oslo University Hospital; Dr. med.
Publications 2021
Genomic and prognostic heterogeneity among RAS/BRAF(V600E)/TP53 co-mutated resectable colorectal liver metastases
Mol. Oncol., 15 (4), 830-845
DOI 10.1002/1878-0261.12885
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
npj Genom. Med., 6 (1), 59
DOI 10.1038/s41525-021-00223-7
ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM Survival Analysis From the Randomized Controlled Trial LIGRO
Ann. Surg., 273 (3), 442-448
DOI 10.1097/SLA.0000000000003701
Response to Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM - It Is Time to Entry the IDEAL Stage 4?"
Ann. Surg., 274 (6), E731-E732
Response to the Comment on "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decisionmaking of Staged Hepatectomy" Reply
Ann. Surg., 274 (6), E750-E751
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
Genome Med., 13 (1), 143
DOI 10.1186/s13073-021-00956-1
The expressed mutational landscape of microsatellite stable colorectal cancers
Genome Med., 13 (1), 142
DOI 10.1186/s13073-021-00955-2
Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial
Trials, 22 (1), 642
DOI 10.1186/s13063-021-05587-w
Publications 2020
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
Clin. Colorectal Canc., 19 (1), E26-E47
DOI 10.1016/j.clcc.2019.09.003
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
Clin. Cancer Res., 26 (15), 4107-4119
DOI 10.1158/1078-0432.CCR-19-3637
Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases
Ann. Surg., 271 (2), 212-218
DOI 10.1097/SLA.0000000000003404
Publications 2019
Laparoscopic versus open liver resection in the posterosuperior segments: a sub-group analysis from the OSLO-COMET randomized controlled trial
HPB, 21 (11), 1485-1490
DOI 10.1016/j.hpb.2019.03.358
Laparoscopic liver resection for non-colorectal non-neuroendocrine metastases: perioperative and oncologic outcomes
World J. Surg. Oncol., 17 (1), 156
DOI 10.1186/s12957-019-1700-y
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases
Ann. Surg., 269 (1), 120-126
DOI 10.1097/SLA.0000000000002319
Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
EJSO, 45 (12), 2340-2346
DOI 10.1016/j.ejso.2019.07.017
Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion: FLR Increase in Patients with CRLM Is Highest the First Week After PVO
J. Gastrointest. Surg., 23 (3), 556-562
DOI 10.1007/s11605-018-4031-3
Short-term outcomes after elective colon cancer surgery: an observational study from the Norwegian registry for gastrointestinal and HPB surgery, NoRGast
Surg. Endosc., 33 (9), 2821-2833
DOI 10.1007/s00464-018-6575-4
Response to Comment on "When Innovation Is Not Enough''
Ann. Surg., 270 (2), E36-E37
DOI 10.1097/SLA.0000000000003028
Response to "ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases"
Ann. Surg., 269 (1), E16-E17
DOI 10.1097/SLA.0000000000003046
Response to the Comment on "Should We Have a Little More Patience With the Conventional 2-Stage Hepatectomy?''
Ann. Surg., 269 (3), E33-E34
DOI 10.1097/SLA.0000000000002739
Publications 2018
Laparoscopic liver resection for metastatic melanoma
Surg. Endosc., 32 (3), 1470-1477
DOI 10.1007/s00464-017-5834-0
Laparoscopic parenchyma-sparing liver resection for colorectal metastases
Radiol. Oncol., 52 (1), 36-41
DOI 10.1515/raon-2017-0046
Survival after resection of colorectal liver metastases in octogenarians and sexagenarians compared to their respective age-matched national population
Hepatobil. Surg. Nutr., 7 (4), 234-241
DOI 10.21037/hbsn.2017.09.03
Laparoscopic Versus Open Resection for Colorectal Liver Metastases The OSLO-COMET Randomized Controlled Trial
Ann. Surg., 267 (2), 199-207
DOI 10.1097/SLA.0000000000002353
The New National Registry for Gastrointestinal Surgery in Norway: NoRGast
Scand. J. Surg., 107 (3), 201-207
DOI 10.1177/1457496918766697
ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)
Ann. Surg., 267 (5), 833-840
DOI 10.1097/SLA.0000000000002511
Publications 2017
Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival
Colorectal Dis., 19 (8), 731-738
DOI 10.1111/codi.13622
Trump's ban on colleagues from Islamic countries
Lancet, 389 (10071), 804
DOI 10.1016/S0140-6736(17)30323-9
Improving the safety of associating liver partition and portal vein ligation for staged hepatectomy
Transl. Cancer Res., 6 3, S560-S563
DOI 10.21037/tcr.2017.04.17
Aspirin, Colorectal Cancer, and Cause of Death: A Complex Landscape Reply
J. Clin. Oncol., 35 (5), 569-+
DOI 10.1200/JCO.2016.70.8263
Proximal signaling responses in peripheral T cells from colorectal cancer patients are affected by high concentrations of circulating prostaglandin E-2
Hum. Immunol., 78 (2), 129-137
DOI 10.1016/j.humimm.2016.10.007
Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases
Ann. Surg. Oncol., 24 (8), 2113-2121
DOI 10.1245/s10434-017-5818-2
Publications 2016
Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study
J. Clin. Oncol., 34 (21), 2501-+
DOI 10.1200/JCO.2015.65.3519
Validation of Clinical Risk Scores for Laparoscopic Liver Resections of Colorectal Liver Metastases: A 10-Year Observed Follow-Up Study
J. Surg. Oncol., 114 (6), 757-763
DOI 10.1002/jso.24391
Associating liver partition and portal vein ligation for staged hepatectomy in patients with colorectal liver metastases - Intermediate oncological results
EJSO, 42 (4), 531-537
DOI 10.1016/j.ejso.2015.12.013
Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study
Acta Oncol., 55 (3), 265-277
DOI 10.3109/0284186X.2015.1068445
Scandinavian multicenter study on the safety and feasibility of the associating liver partition and portal vein ligation for staged hepatectomy procedure
Surgery, 159 (5), 1279-1286
DOI 10.1016/j.surg.2015.10.004
Laparoscopic Resection of Recurrence from Hepatocellular Carcinoma after Liver Transplantation: Case Reports and Review of the Literature
Case Rep. Oncol. Med., 2016, 8946471
DOI 10.1155/2016/8946471
Publications 2015
Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases
Ann. Surg. Oncol., 22 (12), 4029-4037
DOI 10.1245/s10434-015-4482-7
Open versus laparoscopic liver resection for colorectal liver metastases (the Oslo-CoMet study): study protocol for a randomized controlled trial
Trials, 16, 73
DOI 10.1186/s13063-015-0577-5
Inflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases Data From the Oslo-CoMet Trial
Medicine (Baltimore), 94 (42), e1786
DOI 10.1097/MD.0000000000001786
Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single center
Acta Radiol. Open, 4 (7)
DOI 10.1177/2058460115580877
Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival
Ann. Surg., 261 (1), 164-171
DOI 10.1097/SLA.0000000000000580
Publications 2012
Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer
Cancer Immunol. Immunother., 61 (7), 1045-1053
DOI 10.1007/s00262-011-1174-4
Kinetics and Activation Requirements of Contact-Dependent Immune Suppression by Human Regulatory T Cells
J. Immunol., 188 (11), 5459-5466
DOI 10.4049/jimmunol.1101367
Impact of contrast-enhanced intraoperative ultrasound on operation strategy in case of colorectal liver metastasis
Acta Radiol., 53 (10), 1081-1087
DOI 10.1258/ar.2012.120049
Publications 2008
Transcatheter arterial embolization in the management of bleeding duodenal ulcers: A 5.5-year retrospective study of treatment and outcome
Scand. J. Gastroenterol., 43 (2), 217-222
DOI 10.1080/00365520701676443
Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation
Eur. J. Immunol., 38 (3), 640-646
DOI 10.1002/eji.200737529
Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner
Cancer Immunol. Immunother., 57 (6), 813-821
DOI 10.1007/s00262-007-0417-x
Publications 2000
Bilirubinindusert cholestase
Institutt for eksperimentell medisinsk forskning, Universitetet i Oslo, Ullevål sykehus, Oslo, 66 s.
BIBSYS 000864005, ISBN 82-90246-56-0